<DOC>
	<DOC>NCT01448798</DOC>
	<brief_summary>The purpose of this study is to evaluate the use of a hemostatic gelatine-thrombin matrix during athermal nerve-sparing prostate resection compared to conventional hemostasis using electrocautery in patients with localized prostate cancer and to investigate effects on postoperative erectile function and continence.</brief_summary>
	<brief_title>Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Patient age &gt;18 Histologically proven prostate cancer ( Gleason &lt;8; PSA&lt;10ng/ml) Disease confined to prostate in clinical examination Preoperative IEEF5Score&gt;20 Patient is able to give informed consent ASA IVV Prior extensive abdominal surgery Signs for metastatic disease Known allergy against bovine material Patient is unable to give informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>radical prostatectomy</keyword>
	<keyword>robotic surgery</keyword>
	<keyword>erectile dysfunction</keyword>
	<keyword>continence</keyword>
</DOC>